WCRX: Summary for Warner Chilcott plc - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 2:32pm EST - Canadian Markets close in 1 hour and 28 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Warner Chilcott Limited (WCRX)

At 14:16 EST: 24.18 USD

0.38 (1.60%)

MORE ON WCRX

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Warner Chilcott plc (NasdaqNM:WCRX) Delayed quote data

Last Trade:	24.18 USD
Trade Time:	2:16PM EST
Change:	0.38 (1.60%)
Prev Close:	23.80
Open:	23.91
Bid:	24.17 x 1000
Ask:	24.18 x 1200
1y Target Est:	20.29

Day's Range:	23.80 - 24.25
52wk Range:	9.24 - 24.45
Volume:	1,147,829
Avg Vol (3m):	1,920,480
Market Cap:	6.08B
P/E (ttm):	8,060.00
EPS (ttm):	0.00
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Free Annual Reports

Add WCRX to Portfolio

Download Data

HEADLINES

•	WARNER CHILCOTT PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement
	EDGAR Online (Tue 5:13pm)

•	P.&G. May Slow Down Deal-Making, Financial Chief Says
	at The New York Times (Fri, Nov 20)

•	Cramer's 'Stop Trading!': Dell vs. Hewlett-Packard
	at TheStreet.com (Fri, Nov 20)

•	P&G repurchasing shares, quiet on potential deals
	Reuters (Fri, Nov 20)

•	Warner Chilcott prices secondary stock offering
	AP (Fri, Nov 20)

•	UPDATE - P&G repurchasing shares, quiet on potential deals
	at Reuters (Fri, Nov 20)

•	Warner Chilcott Prices Secondary Equity Offering
	PRNewswire (Thu, Nov 19)

•	WARNER CHILCOTT PLC Financials
	EDGAR Online Financials (Fri, Nov 13)

•	Funds to sell 20M Warner Chilcott shares
	AP (Fri, Nov 13)

•	Warner Chilcott Announces Secondary Equity Offering
	PRNewswire (Fri, Nov 13)

More Headlines for WCRX...

ANALYST

EPS Est (next year) (Dec-07) :	1.07
EPS Est (in 2 years) (Dec-08) :	1.28
Avg Rec (current)*:	2.3
PEG Ratio:	0.84

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Warner Chilcott Limited, a specialty pharmaceutical company, engages in the development, manufacture, marketing, and sale of branded prescription pharmaceutical products in women's healthcare and dermatology primarily in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•